Insider Transactions in Q1 2021 at Rubius Therapeutics, Inc. (RUBY)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
210,000
+1.41%
|
$6,090,000
$29.0 P/Share
|
|
Mar 15
2021
|
Maiken Keson Brookes CLO & Corp. Secretary |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$500,000
$20.24 P/Share
|
|
Mar 15
2021
|
Maiken Keson Brookes CLO & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$175,000
$7.7 P/Share
|
|
Feb 11
2021
|
David R Epstein Director |
SELL
Open market or private sale
|
Direct |
26,704
-0.57%
|
$373,856
$14.93 P/Share
|
|
Feb 10
2021
|
David R Epstein Director |
SELL
Open market or private sale
|
Direct |
7,404
-0.16%
|
$103,656
$14.79 P/Share
|
|
Feb 09
2021
|
David R Epstein Director |
SELL
Open market or private sale
|
Direct |
2,100
-0.04%
|
$29,400
$14.83 P/Share
|
|
Feb 08
2021
|
David R Epstein Director |
SELL
Open market or private sale
|
Direct |
89,233
-1.85%
|
$1,249,262
$14.88 P/Share
|